Worth Seeing!
Top Stocks to Buy: Get Access to 13 High-Conviction Stock Recommendations that We Strongly Believe In - Invest with Confidence Today! Get Access Now Get Access Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 74005.94
0 (0.00%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
31
Fortis Healthcare Ltd.
34,139
(Mid Cap)
453
(0.00%)
256.32
3.79
9.81
0.00
Unlock
32
Sun Pharma Advanced Research Company Ltd.
7,123
(Small Cap)
219.55
(0.00%)
N/A
30.7
24.99
0.00
Unlock
33
Natco Pharma Ltd.
17,899
(Small Cap)
999.35
(0.00%)
14.01
3.25
4.38
0.36
Unlock
34
Hester Biosciences Ltd.
1,489
(Small Cap)
1,762.15
(0.00%)
54.83
4.76
13.51
0.65
Unlock
35
Bliss GVS Pharma Ltd.
1,156
(Small Cap)
111
(0.00%)
22.83
1.17
14.97
1.73
Unlock
36
FDC Ltd.
7,857
(Small Cap)
485
(0.00%)
26.53
3.83
10.84
3.42
Unlock
37
Ajanta Pharma Ltd.
30,157
(Mid Cap)
2,391.85
(0.00%)
36.95
8.45
11.98
4.54
Unlock
38
Metropolis Healthcare Ltd.
9,417
(Small Cap)
1,846.80
(0.00%)
75.48
8.77
12.15
6.00
Unlock
39
Eris Lifesciences Ltd.
12,206
(Small Cap)
892.50
(0.00%)
31.58
4.86
14.52
6.67
Unlock
40
Medicamen Biotech Ltd.
683
(Small Cap)
536.95
(0.00%)
47.94
3.39
4.34
7.42
Unlock
41
Healthcare Global Enterprises Ltd.
5,005
(Small Cap)
359.15
(0.00%)
125.43
4.22
11.39
7.94
Unlock
42
Alkem Laboratories Ltd.
65,029
(Mid Cap)
5,421.75
(0.00%)
38.78
6.11
11.39
9.10
Unlock
43
Morepen Laboratories Ltd.
2,447
(Small Cap)
47.95
(0.00%)
30.12
2.87
19.01
9.18
Unlock
44
Lupin Ltd.
75,652
(Mid Cap)
1,661.90
(0.00%)
39.52
5.29
1.04
9.19
Unlock
45
Advanced Enzyme Technologies Ltd.
4,196
(Small Cap)
374.10
(0.00%)
38.8
7.23
8.00
9.23
Unlock
46
Sanofi India Ltd.
20,331
(Small Cap)
8,820.75
(0.00%)
37.01
18.76
0.57
9.48
Unlock
47
Novartis India Ltd.
2,763
(Small Cap)
1,113
(0.00%)
32.43
3.71
-7.65
9.95
Unlock
48
Syncom Formulations (India) Ltd.
1,277
(Small Cap)
13.58
(0.00%)
54.03
4.62
7.21
10.35
Unlock
49
Pfizer Ltd.
20,467
(Small Cap)
4,438.10
(0.00%)
37.12
5.69
4.26
11.01
Unlock
50
Glaxosmithkline Pharmaceuticals Ltd.
39,908
(Mid Cap)
2,358.10
(0.00%)
67.64
22.45
2.52
11.21
Unlock
51
Dr. Lal Pathlabs Ltd.
21,170
(Small Cap)
2,532.85
(0.00%)
55.07
11.14
11.55
11.64
Unlock
52
NGL Fine-Chem Ltd.
1,441
(Small Cap)
2,336.35
(0.00%)
39.8
5.72
19.33
11.86
Unlock
53
Mankind Pharma Ltd.
84,596
(Large Cap)
2,114.90
(0.00%)
46.39
8.79
15.71
13.53
Unlock
54
Shalby Ltd.
3,005
(Small Cap)
273.85
(0.00%)
30.16
2.89
13.24
14.33
Unlock
55
Cipla Ltd.
1,13,357
(Large Cap)
1,403.90
(0.00%)
27.5
4.24
8.47
14.67
Unlock
56
Divis Laboratories Ltd.
1,04,235
(Large Cap)
3,918.75
(0.00%)
75.37
8
14.82
15.00
Unlock
57
Kovai Medical Center & Hospital Ltd.
4,450
(Small Cap)
4,062
(0.00%)
28.14
5.33
11.48
15.15
Unlock
58
Aster DM Healthcare Ltd.
17,376
(Small Cap)
347.85
(0.00%)
53.61
3.79
12.17
15.37
Unlock
59
Aarti Drugs Ltd.
4,491
(Small Cap)
489.25
(0.00%)
26.2
3.5
16.91
15.52
Unlock
60
Syngene International Ltd.
27,735
(Mid Cap)
690
(0.00%)
59.45
6.62
17.55
15.81
Unlock
2

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

News about Top Pharma Companies in India

USFDA concludes pre approval inspection at Lupin’s Somerset manufacturing facility

The inspection was conducted from May 7, 2024 to May 17, 2024
20 May, 2024

Divi’s Laboratories informs about conference call

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi’s Laboratories has informed that it enclosed the schedule of earnings conference call for the 4th quarter and year ended March 31, 2024 to be held on May 25, 2024 at 14:30 hrs (IST).

The above information is a part of company’s filings submitted to BSE.

20 May, 2024

Pfizer - Quaterly Results

A slight decline in the revenue of Rs. 5466.30 millions was seen for the March 2024 quarter as against Rs. 5726.40 millions during year-ago period.The company has announced a 37.96% increase in its profits to Rs . 1788.60  millions for the  quarter ended March 2024 compared to Rs. 1296.50 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 2645.60 millions from 2132.50 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5466.30 5726.40 -4.54 21931.70 24247.60 -9.55 21931.70 24247.60 -9.55
Other Income 751.30 313.80 139.42 1805.10 1010.50 78.63 1805.10 1010.50 78.63
PBIDT 2645.60 2132.50 24.06 8158.10 9099.10 -10.34 8158.10 9099.10 -10.34
Interest 69.50 25.30 174.70 154.10 133.90 15.09 154.10 133.90 15.09
PBDT 2576.10 1911.30 34.78 8083.50 9295.20 -13.04 8083.50 9295.20 -13.04
Depreciation 137.50 264.10 -47.94 622.80 1055.10 -40.97 622.80 1055.10 -40.97
PBT 2438.60 1647.20 48.05 7460.70 8240.10 -9.46 7460.70 8240.10 -9.46
TAX 650.00 350.70 85.34 1947.40 2000.80 -2.67 1947.40 2000.80 -2.67
Deferred Tax 163.10 -315.30 -151.73 361.10 -519.10 -169.56 361.10 -519.10 -169.56
PAT 1788.60 1296.50 37.96 5513.30 6239.30 -11.64 5513.30 6239.30 -11.64
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 48.40 37.24 29.96 37.20 37.53 -0.87 37.20 37.53 -0.87
17 May, 2024

Pfizer - Quaterly Results

Revenue showed a marginal decline at Rs. 5466.30 millions. For the quarter ended March 2024, as compared to corresponding quarter of last year.The company has announced a 37.96% increase in its profits to Rs . 1788.60  millions for the  quarter ended March 2024 compared to Rs. 1296.50 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended March 2024 rose to 2645.60 millions as compared to 2132.50 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5466.30 5726.40 -4.54 21931.70 24247.60 -9.55 21931.70 24247.60 -9.55
Other Income 751.30 313.80 139.42 1805.10 1010.50 78.63 1805.10 1010.50 78.63
PBIDT 2645.60 2132.50 24.06 8158.10 9099.10 -10.34 8158.10 9099.10 -10.34
Interest 69.50 25.30 174.70 154.10 133.90 15.09 154.10 133.90 15.09
PBDT 2576.10 1911.30 34.78 8083.50 9295.20 -13.04 8083.50 9295.20 -13.04
Depreciation 137.50 264.10 -47.94 622.80 1055.10 -40.97 622.80 1055.10 -40.97
PBT 2438.60 1647.20 48.05 7460.70 8240.10 -9.46 7460.70 8240.10 -9.46
TAX 650.00 350.70 85.34 1947.40 2000.80 -2.67 1947.40 2000.80 -2.67
Deferred Tax 163.10 -315.30 -151.73 361.10 -519.10 -169.56 361.10 -519.10 -169.56
PAT 1788.60 1296.50 37.96 5513.30 6239.30 -11.64 5513.30 6239.30 -11.64
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 48.40 37.24 29.96 37.20 37.53 -0.87 37.20 37.53 -0.87
17 May, 2024

Syncom Formulations - Quaterly Results

A fair growth of 19.39% in the revenue at Rs. 732.66 millions was reported in the March 2024 quarter as compared to Rs. 613.69 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 67.47  millions from Rs. 84.66 millions ,decline by -20.30%.The company reported a degrowth in operating Profit to 116.75 millions from 127.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 732.66 613.69 19.39 2583.60 2246.44 15.01 2583.60 2246.44 15.01
Other Income 28.71 67.79 -57.65 131.01 146.10 -10.33 131.01 146.10 -10.33
PBIDT 116.75 127.17 -8.19 409.55 342.22 19.67 409.55 342.22 19.67
Interest 11.70 12.92 -9.44 44.49 31.30 42.14 44.49 31.30 42.14
PBDT 105.05 114.38 -8.16 364.82 311.05 17.29 364.82 311.05 17.29
Depreciation 12.98 11.68 11.13 47.22 45.39 4.03 47.22 45.39 4.03
PBT 92.07 102.70 -10.35 317.60 265.66 19.55 317.60 265.66 19.55
TAX 24.60 18.04 36.36 81.36 64.95 25.27 81.36 64.95 25.27
Deferred Tax 0.43 -7.84 -105.48 5.54 -1.53 -462.09 5.54 -1.53 -462.09
PAT 67.47 84.66 -20.30 236.24 200.71 17.70 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.94 20.72 -23.10 15.85 15.23 4.06 15.85 15.23 4.06
17 May, 2024

Syncom Formulations - Quaterly Results

A fair growth of 19.39% in the revenue at Rs. 732.66 millions was reported in the March 2024 quarter as compared to Rs. 613.69 millions during year-ago period.A slender decline of -20.30% was recorded to Rs. 67.47  millions from Rs. 84.66 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 116.75 millions from 127.17 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 732.66 613.69 19.39 2583.60 2246.44 15.01 2583.60 2246.44 15.01
Other Income 28.71 67.79 -57.65 131.01 146.10 -10.33 131.01 146.10 -10.33
PBIDT 116.75 127.17 -8.19 409.55 342.22 19.67 409.55 342.22 19.67
Interest 11.70 12.92 -9.44 44.49 31.30 42.14 44.49 31.30 42.14
PBDT 105.05 114.38 -8.16 364.82 311.05 17.29 364.82 311.05 17.29
Depreciation 12.98 11.68 11.13 47.22 45.39 4.03 47.22 45.39 4.03
PBT 92.07 102.70 -10.35 317.60 265.66 19.55 317.60 265.66 19.55
TAX 24.60 18.04 36.36 81.36 64.95 25.27 81.36 64.95 25.27
Deferred Tax 0.43 -7.84 -105.48 5.54 -1.53 -462.09 5.54 -1.53 -462.09
PAT 67.47 84.66 -20.30 236.24 200.71 17.70 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.94 20.72 -23.10 15.85 15.23 4.06 15.85 15.23 4.06
17 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Sequent Scientific Ltd. 2,903 Crore
2 Solara Active Pharma Sciences Ltd. 2,324 Crore
3 Shilpa Medicare Ltd. 4,906 Crore
4 Suven Life Sciences Ltd. 2,192 Crore
5 Strides Pharma Science Ltd. 8,009 Crore
6 SMS Pharmaceuticals Ltd. 1,741 Crore
7 Sastasundar Ventures Ltd. 944 Crore
8 Glenmark Pharmaceuticals Ltd. 29,407 Crore
9 Jubilant Pharmova Ltd. 11,416 Crore
10 Dishman Carbogen Amcis Ltd. 3,082 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,821 20,331 37.01 18.76 23.75 51.69
Abbott India Ltd. (M) Very Good 26,618 56,616 47.13 15.31 32.02 31.69
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 97,001 17.39 3.43 10.98 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,699 91,556 61.28 12.80 29.38 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Zydus Lifesciences Ltd. (L) Very Good 1,104 1,11,134 117.7
Lupin Ltd. (M) Somewhat Good 1,662 75,652 113.0
Aurobindo Pharma Ltd. (M) Very Good 1,204 70,468 100.7
Ipca Laboratories Ltd. (M) Very Good 1,311 33,258 94.25
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 82.76
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 24.05
Granules India Ltd. (S) Somewhat Good 405.5 9,856 22.61 3.17 13.23 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 52.57 9.90 31.56 18.11
Gland Pharma Ltd. (M) Very Good 1,768 29,304 36.58 3.38 20.84 17.42
Mankind Pharma Ltd. (L) Very Good 2,115 84,596 46.39 8.79 32.35 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 97,001 17.39 3.43 10.98 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 52.57 9.90 31.56 31.92
Biocon Ltd. (M) Somewhat Good 304.9 36,582 306.6 3.35 83.47 31.80
Granules India Ltd. (S) Somewhat Good 405.5 9,856 22.61 3.17 13.23 31.51
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.